BFRI
Biofrontera Inc.Company with tickers: BFRI, BFRIW
CIK
1858685
CUSIP
09077D209
Shares Outstanding
12,803,344
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $10,084,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $14,404,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $900,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-4,320,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-4,752,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.41 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.41 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |